Diabetes Autoimmunity Withdrawn in New Onset Patients (DAWN)

NCT03794973 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Modification to Clinical Development Plan

Conditions

Diabetes Mellitus, Type 1

Interventions

BIOLOGICAL: TOL-3021
OTHER: TOL-3021 Placebo

Sponsor

Tolerion, Inc.